Mylan Pharmaceuticals Inc Mycophenolate Mofetil for Injection USP, 500 mg/Vial recall: Presence of precipitate
Presence of precipitate
The hazard: Drug safety concern
The product was withdrawn from distribution. Whether your own pack is affected comes down to the lot number.
What the notice says: Presence of precipitate
Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.
Recall details
- Recall number
- D-0734-2026
- Published
- August 5, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Mylan Pharmaceuticals Inc
- Product type
- Prescription & OTC drugs
- Units affected
- 5688 vials
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot #: 3241653, Exp 4/30/2027
Products covered by this recall
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Check your product
The notice names 9 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 3241653
- Exp 4
- 30
- 2027 — 5688 vials
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 30
- 2027 — 5688 vials
NDC number
On the carton and again on the bottle or blister label.
- 67457-386-00
- 67457-386-81
Package size
Match the net weight or the piece count on the front of the pack.
- 500 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Drug safety
Mylan Pharmaceuticals Inc — The product was withdrawn from distribution. Whether your own pack is affected comes down to the lot number.
- Check the lot number on your pack against the codes listed above.
- Ask the dispensing pharmacy for a replacement from an unaffected lot.
- Keep the carton; the lot number is often printed only on the outer pack.
- Report side effects you think the product caused to FDA MedWatch.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: MYLAN PHARMACEUTICALS INC — 1311 Pineview Dr, Morgantown, WV, 26505-3276
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Mylan Pharmaceuticals Inc prescription & otc drugs recalled?
Presence of precipitate Presence of precipitate
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 3241653, Exp 4, 30; best-by date 30 or 2027 — 5688 vials. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · last month
Mylan Pharmaceuticals Inc Prasugrel Tablets, USP, 10mg recall: Failed Dissolution Specifications; product failed to meet 18-month stability
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
-
Class II · last month
Mylan Pharmaceuticals Inc Carton label: Mycophenolate Mofetil for injection, USP recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 2 months ago
Mylan Pharmaceuticals Inc Acamprosate Calcium, Delayed-Release Tablets, 333 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 8 months ago
Mylan Pharmaceuticals Inc Amnesteem Capsules, USP 40 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 11 days ago
Carolina Infusion, LLC Quad-Mix Injectable, Packaged in single-use dosage syringes recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.